美国核心脏病学会心脏淀粉样变放射性核素显像质量指标
美国核心脏病学会基于临床指南、适用标准、信息与立场声明及专家意见,制定15项质量指标,围绕适当适应证、患者体验与流程、仪器与方案、判读与报告4个维度,评估心脏淀粉样变放射性核素显像实验室质量,用于识别不足并推动质量改进。
要点
- 所有疑似心脏淀粉样变患者应进行实验室检查以排除浆细胞病。
- 所有患者的判读应基于SPECT而非平面显像。
- 报告应包含充分技术细节,结论应清晰明确以指导临床管理。
核心结论
- 实验室可使用这些指标数据识别不足并开展质量改进举措,最终改善患者结局。
研究设计与样本
- 美国核心脏病学会制定质量指标的文件,指标基于临床指南、适用标准、信息与立场声明及专家意见。
- 文件提出15项质量指标,围绕4个维度:A适当适应证;B患者体验与流程;C仪器与方案;D判读与报告。
主要发现
- 文件提出15项质量指标,围绕适当适应证、患者体验与流程、仪器与方案、判读与报告4个维度。
关键数值与推荐
- 所有疑似心脏淀粉样变患者应进行实验室检查以排除浆细胞病。
- 所有患者的判读应基于SPECT而非平面显像。
- 报告应包含充分技术细节以允许正确判读研究结果,结论应清晰明确以指导临床管理。
临床怎么用
- 实验室应在适当选择的患者中进行显像,避免低价值显像。
- 检测前应向患者提供适当教育,必须及时获得检测,患者体验与满意度的定期评估应成为常规。
- 应严格遵循既定方案并定期评估实验室质量控制。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This document from the American Society of Nuclear Cardiology develops metrics for the assessment of quality for laboratories that perform cardiac amyloid radionuclide imaging. These metrics are based on clinical guidelines, appropriate use criteria, information and position statements, and expert opinion. The document introduces 15 quality metrics that address current gaps in care organized around 4 axes: A) Appropriate indications; B) Patient experience and workflow; C) Instrumentation and protocols; and D) Interpretation and reporting. With the increasing use of imaging for cardiac amyloid, it is imperative that our laboratories maintain a high level of quality to preserve the value that imaging provides to patients. Laboratories should perform imaging in appropriately selected patients avoiding low-value imaging. Proper education should be provided to patients prior to performing testing, timely access to testing must be available, and periodic assessment of patient experience and satisfaction should be the norm. Strict adherence to established protocols with periodic assessment of laboratory quality control is essential. Laboratory studies to rule out plasma cell dyscrasia should be performed in all patients suspected of having cardiac amyloidosis. Crucially, interpretation should be based on SPECT rather than planar imaging in all patients. The study report should include sufficient technical details to allow for proper interpretation of study findings and its conclusion should be clear and unambiguous to guide clinical management. Laboratories can use data derived from these metrics to identify areas of deficiency and introduce quality improvement initiatives, which will ultimately improve patient outcomes.
引用
- Hage FG, Bourque JM, Pandey S, et al. American Society of Nuclear Cardiology quality metrics for cardiac amyloid radionuclide imaging. J Nucl Cardiol. 2024. PMID: 40590833. doi:10.1016/j.nuclcard.2024.102041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。